IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 49 filers reported holding IKENA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,303,721 | -42.0% | 4,458,134 | -12.1% | 0.00% | -33.3% |
| Q2 2023 | $33,264,593 | +45.5% | 5,070,822 | -23.5% | 0.00% | +200.0% |
| Q1 2023 | $22,862,358 | +130.8% | 6,626,770 | +77.9% | 0.00% | 0.0% |
| Q4 2022 | $9,907,369 | +10.5% | 3,724,575 | +47.4% | 0.00% | 0.0% |
| Q3 2022 | $8,968,000 | -53.9% | 2,526,203 | -42.5% | 0.00% | -50.0% |
| Q2 2022 | $19,473,000 | -31.6% | 4,395,719 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $28,453,000 | -52.0% | 4,664,461 | -1.3% | 0.00% | -50.0% |
| Q4 2021 | $59,235,000 | -6.7% | 4,723,687 | -6.1% | 0.00% | -20.0% |
| Q3 2021 | $63,493,000 | +5.0% | 5,031,140 | +13.5% | 0.01% | 0.0% |
| Q2 2021 | $60,466,000 | -39.3% | 4,431,657 | +17.3% | 0.01% | -44.4% |
| Q1 2021 | $99,659,000 | – | 3,777,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |